AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study

NAActive, not recruitingINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions

OsteoarthritisArthritisAvascular NecrosisFracture of the Femoral Neck or HeadCongenital Hip Dysplasia

Interventions

DEVICE

AMIStem Hip System

Trial Locations (2)

Uniklinik Balgrist, Zurich

The Elective Orthopaedic Centre (EOC), Epsom